<DOC>
	<DOCNO>NCT02537366</DOCNO>
	<brief_summary>Crossover randomize control double blind trial : - The primary endpoint duration Non Invasive Ventilation ( NIV ) session ( minute ) dexmedetomidine ( DEX ) placebo . - Secondary endpoint sedation level assess Richmond Agitation Sedation Scale ( RASS ) , number intervention allow completion NIV session , pain intensity level assess visual analogue scale , morphine ketamine consumption NIV session , comparison blood gas measurement NIV session , reproducibility NIV cycle . The side effect DEX notify .</brief_summary>
	<brief_title>Dexmedetomidine Non-invasive Ventilation After Chest Trauma</brief_title>
	<detailed_description />
	<mesh_term>Thoracic Injuries</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Blunt chest trauma thoracic trauma score &gt; 6 , ICU admission spontaneous breathe Contra indication NIV Dexmedetomidine specify French marketing authorization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>